Wealth Enhancement Trust Services
GOSS icon

Wealth Enhancement Trust Services’s Gossamer Bio GOSS Stock Holding History

Wealth Enhancement Trust Services’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-38
Closed -$500 – 1075
2026
Q2 		$500 Buy
+38
New +$849 ﹤0.01% 1244

Other funds holding GOSS

Context Capital Management
Context Capital Management Lajolla, California $4.89B AUM 1.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Worth Venture Partners
Worth Venture Partners Fort Lee, New Jersey $38.9M AUM 12.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
MB Generational Wealth
MB Generational Wealth Spokane, Washington $196M AUM 14.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Monaco Asset Management
Monaco Asset Management Monaco $818M AUM 32.61% 1-Year Est. Return

Wealth Enhancement Trust Services's GOSS Position: Q3 2026 in Review

Wealth Enhancement Trust Services sold out of Gossamer Bio (GOSS) in Q3 2026, closing a stake of 38 shares — an estimated $500 sold.

Wealth Enhancement Trust Services first reported a position in GOSS in Q2 2026 and held it in 1 quarter. The position peaked at $500 in Q2 2026. 35 funds tracked by Wall St. Rank hold GOSS as of Q3 2026.

  • Wealth Enhancement Trust Services reported no remaining Gossamer Bio position as of Q3 2026 after selling out during the quarter.
  • Wealth Enhancement Trust Services sold 38 Gossamer Bio shares in Q3 2026, an estimated $500.
  • Wealth Enhancement Trust Services first reported a position in Gossamer Bio in Q2 2026 and held it in 1 quarter.
  • Wealth Enhancement Trust Services's Gossamer Bio position peaked at $500 in Q2 2026.
  • 35 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q3 2026, filed 7 Oct 2026.